Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2003
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104485 Antibodies specific for osteoprotegerin binding proteins and method of use
06/05/2003US20030104455 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524
06/05/2003US20030104400 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infammatory, immunol;ogical and nervous system disorders
06/05/2003US20030104389 Synthesis of biologically active compounds in cells
06/05/2003US20030104377 Tenascin-C nucleic acid ligands
06/05/2003US20030104090 For human and nonhuman animals containng a bixin, which may be bixin, norbixin, methylbixin, higher alkyl esters and diesters of norbixin, isomers thereof, and extracts of the Bixa orellana seed.
06/05/2003US20030104089 Induced by urethane or by (((4-N-methyl-N-nitrosoamino)-1-(3-pyridyl)-1-butanone)))
06/05/2003US20030104088 Sulfated proteoglycan; one or more of a hexosamine sulfate,a flavone, olive kernel extract, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of CRH, caffeine, and a polyamine.
06/05/2003US20030104087 Proteoglycan compositions for treating arthritic inflammatory conditions
06/05/2003US20030104085 Administering a vanilloid receptor agonist, preferably a capsaicin or resiniferatoxin
06/05/2003US20030104082 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex.
06/05/2003US20030104081 Composition for treating obesity and esthetic treatment process
06/05/2003US20030104079 Prevention, treatment or therapy of organic diseases causing histopathological changes of the vital or viable tissues; wound healing promoters; plant and animal growth regulators
06/05/2003US20030104078 Method of improving the antioxidant status of an infant
06/05/2003US20030104077 Relieving symptoms of erectile dysfunction with proanthocyanidins
06/05/2003US20030104075 Products containing polyphenol (s) and L-arginine to stimulate nitric oxide production
06/05/2003US20030104073 Methods for enhancing fluid flow through an obstructed vascular site, and systems and kits for use in practicing the same
06/05/2003US20030104065 Method of preparing solid dispersions
06/05/2003US20030104063 Low-solubility drug and a matrix combined with a concentration- enhancing polymer. improves stability and/ or enhances concentration
06/05/2003US20030104062 Shell-and-core dosage form approaching zero-order drug release
06/05/2003US20030104061 Controlled release tramadol preparations with a storage-stable release profile and process for their production
06/05/2003US20030104060 Fenofibrate pharmaceutical composition having high bioavailability
06/05/2003US20030104059 Combination of non-ionic and anionic hydrophilic polymers, especially hydroxypropyl methyl cellulose and sodium carboxymethyl cellulose
06/05/2003US20030104057 Mixed witha polymeric carrier to produce a certain dissolution profile; follows a zero-order release pattern producing flat plasma levels of valproate, once steady-state levels have been achieved; side effect reduction
06/05/2003US20030104055 Antibiotic product, use and formulation thereof
06/05/2003US20030104053 Drug dispersed in a solid unitary matrix formed of poly(ethylene oxide) and hydroxypropyl methylcellulose.
06/05/2003US20030104052 Matrix of a biocompatible, hydrophilic, erodible polymer with an active agent incorporated therein; polymer swells in water and gradually erodes with contact with gastric fluid
06/05/2003US20030104051 Fenofibrate pharmaceutical composition having high bioavailability
06/05/2003US20030104050 Process for preparing quick dissolving, high loading ribavirin compositions
06/05/2003US20030104049 Metformin Hydrochloride tablets
06/05/2003US20030104048 Pharmaceutical dosage forms for highly hydrophilic materials
06/05/2003US20030104046 High-concentration lidocaine compositions and methods for their preparation
06/05/2003US20030104043 Topical cream for alleviating spider veins
06/05/2003US20030104041 Transdermal and topical administration of drugs using basic permeation enhancers
06/05/2003US20030104035 Sitostanol containing at least 10% campestanol; lower serum cholesterol levels when incorporated in foods
06/05/2003US20030104033 Contain caseinate and another protein, preferably soybean protein or whey; reduced rate of creaming and an enhanced shelf life.
06/05/2003US20030104031 Controlled release polymeric compositions of bone growth promoting compounds
06/05/2003US20030104029 Resorbable polymer composition, implant and method of making implant
06/05/2003US20030104020 Chitosan compositions
06/05/2003US20030104017 One sweetener or flavor masks quick-acting bitterness and another masks long-acting bitterness
06/05/2003US20030104016 Reducing inflammation by topically applying totarol or an ester of totarol
06/05/2003US20030104015 Emulsion or micellar solution of alpha-tocopherol, one or more surfactants (e.g., a vitamin E derivative), an aqueous phase, and a therapeutic agent
06/05/2003US20030104014 Method for the treatment of malignant and infectious chronic diseases
06/05/2003US20030104013 Inhibitor of histamine synthesis, especially of of histidine decarboxylase such as tritoqualine; allergen, e.g., cysteine protease
06/05/2003US20030104007 Pseudopterosin compounds of Symbiodinium spp isolated from Pseudopterogorgia elisabethae
06/05/2003US20030104004 Food product suitable for reducing low density lipoprotein cholesterol levels
06/05/2003US20030103998 Treatment of HIV and other viral infections using combinatorial therapy
06/05/2003US20030103995 Detection and therapy of vulnerable plaque with photodynamic compounds
06/05/2003US20030103983 Ace inhibitor-vasopressin antagonist combinations
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103959 Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor
06/05/2003US20030103955 For topical application; high penetration through skin; antiinflammatory agents
06/05/2003US20030103954 Comprises vitamin D3 for regulating cell differentiation and/or cell proliferation
06/05/2003US20030103953 Comprises vitamin D3 for controlling cell differentiation and/or cell proliferation
06/05/2003US20030103938 Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
06/05/2003US20030103932 Compositions, methods and devices for treatment of urethral disorders
06/05/2003US20030103931 Crosslinked polylysine
06/05/2003US20030103924 Mixture containing polymeric carrier
06/05/2003US20030103912 Breaking, disrupting film in aqueous solution; preventioncoagulation
06/05/2003US20030103908 Aerosol form; mixture with sugar and liquid carrier
06/05/2003US20030103907 Suspension aerosol formulations
06/05/2003US20030103899 Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans
06/05/2003US20030103896 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents
06/05/2003US20030103864 Sterilization of pharmaceuticals
06/05/2003US20030102109 Cooling apparatus
06/05/2003CA2837936A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2563052A1 Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.02,11.0 4,9]-hexadeca-2(11)3,5,7,9-pentaene
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2477585A1 Amino acid derivatives useful for the treatment of alzheimer's disease
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2468706A1 Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
06/05/2003CA2468705A1 Succinic acid salts of 5,8,14-triazatetracyclo'10.3.1.0<2,11>.0<4,9>-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
06/05/2003CA2468575A1 Oral immunostimulation of mammals, birds, fish and reptiles from (1-4) linked .beta.-d-mannuronic acid
06/05/2003CA2468548A1 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468494A1 Pharmaceutical compositions and methods for administering ep2 receptor selective agonists
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468408A1 Human cdnas and proteins and uses thereof
06/05/2003CA2468402A1 Ccr-3 receptor antagonists vii
06/05/2003CA2468390A1 Treatment of wounds and compositions employed
06/05/2003CA2468380A1 Use of n-(indolecarbonyl)piperazine derivatives
06/05/2003CA2468344A1 Methods and compositions for treating lesions of the respiratory epithelium
06/05/2003CA2468320A1 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist
06/05/2003CA2468312A1 Single nucleotide polymorphisms and combinations thereof predictive for paclitaxel responsiveness
06/05/2003CA2468301A1 Method of fattening poultry
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003CA2468256A1 Compositions comprising phenyl-glycine derivatives
06/05/2003CA2468246A1 Increasing electro-gene transfer of nucleic acid molecules into host tissue
06/05/2003CA2468192A1 Peptidomimetic inhibitors of post-proline cleaving enzymes
06/05/2003CA2468187A1 Peptides with growth inhibitory action
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468181A1 Hydroperylene derivatives
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468135A1 Ginger extract preparation
06/05/2003CA2468131A1 Disruption of the prostaglandin e synthase 2 gene
06/05/2003CA2468071A1 Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives, compositions containing same, preparation method and use thereof
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2468010A1 Benzazepine derivatives and their use as 5-ht ligands
1 ... 5446 5447 5448 5449 5450 5451 5452 5453 5454 5455 5456 5457 5458 5459 5460 5461 5462 5463 5464 5465 5466 ... 7860